Remala Abadi Tbk. vs Phapros Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp2,450 (market cap 3.29T, 15.47M 24h volume), while Phapros Tbk. trades at Rp256 (market cap 211.68B, 116.4K 24h volume). The key difference: Remala Abadi Tbk. is far larger — about 15.5× Phapros Tbk.'s market cap, and Remala Abadi Tbk. is more actively traded (15.47M versus 116.4K). Which is the better fit depends on your goals.
| DATA | PEHA | |
|---|---|---|
Market Cap | 3.29T | 211.68B |
Volume | 15.47M | 116.4K |
Lot | 154.74K | 1.16K |
Turnover | 37.99B | 29.27M |
Average Price | 2,454.89 | 251.47 |
Value | 37.99B | 29.27M |
Indicative Equilibrium Price | 2,450 | 256 |
Indicative Equilibrium Volume | 2.17K | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →